Autoimmune Diseases Working Party (ADWP)
Study type:
Study number:
2006-004598-83
Type of Stem Cell Treatment:
Diseases:
Auto immune disorders
Short title:
ASTIS
Primary objective:
To evaluyate the potential clinical benefit of high dose immunoablation and autologous stem cell transplantation in comparison to intravenous pulse therapy cyclophosphamide, with respect to survival and prevention of major organ failure, safety, impact on skin thickening, visceral involvement, functional status and quality of life.
Key inclusion criteria:
18-65 years
Country:
Austria
Belgium
Canada
France
Germany
Greece
Italy
Netherlands
Switzerland
United Kingdom
Principal investigator:
J.M. van Laar
EBMT Study coordinator:
Ruzena Uddin